EXEL: financial statements from SEC — TradeAlmanac

EXEL

Exelixis, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Revenue	611m	598m	568m	555m	540m	637m
Cost of revenue	20m	19m	19m	19m	17m	18m
Research and development	200m	199m	200m	212m	223m	211m
Selling, general and administrative	140m	124m	135m	137m	112m	132m
Operating expenses	359m	361m	355m	369m	403m	361m
Operating income	251m	237m	214m	187m	136m	276m
Income tax	57m	59m	46m	46m	37m	67m
Net income	210m	194m	185m	160m	118m	226m
Earnings per share	0.81	0.72	0.68	0.57	0.41	0.78
Earnings per share, diluted	0.79	0.69	0.65	0.55	0.40	0.77
Weighted average shares	258m	268m	273m	279m	286m	289m
Weighted average shares, diluted	267m	279m	284m	288m	291m	294m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	226m	482m	376m	164m	184m	217m	258m	198m
Short-term investments	551m	577m

Cash flow

Metric	Mar 31, 2026	Mar 31, 2025
Operating cash flow	252m	211m
Depreciation and amortisation	7m	7m
Share-based compensation	29m	26m
Capital expenditure	2m	3m
Investing cash flow	−51m	50m
Share buybacks	430m

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)